Literature DB >> 843177

Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy.

S C Goldberg, N R Schooler, G E Hogarty, M Roper.   

Abstract

Despite the established efficacy of neuroleptics for maintaining schizophrenics in the community, there are data suggesting that those with very good prognostic signs may do as well without drugs. In testing this, we find no evidence that patients with good signs are not in need of drugs; instead they profit most from drug treatment. Patients who benefit little (1) are men whose families were disrupted earlier in their lives, (2) live alone or with extended families whose attitudes toward the study are not positive, and (3) are irregular in taking their medication. The practical implication is that the drug nonresponder can be helped by some means to ensure regularity of medication taking, such as a visiting nurse or long-acting medication. A second research question is whether major role therapy (MRT, a combination of social casework and vocational rehabilitation) can lengthen the time until relapse. Major role therapy affected time to relapse in a disordinal manner; asymptomatic patients benefited from MRT, while in patients with greater symptom severity MRT- suprisingly--hastened relapse. It is hypothesized that symptomatic patients are suffering from an inability to manage an expanded and enriched cognitive field; MRT, a therapy that urges the patient to become more responsible and to expand his horizons, may actually induce a state with which the patient cannot cope. It is recommended that a therapy such as MRT be deferred until the patient is essentially asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843177     DOI: 10.1001/archpsyc.1977.01770140061008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  20 in total

1.  Development of clinical methods for utilization review in psychiatric day treatment.

Authors:  K G Terkelsen; R H McCarthy; R L Munich; B E Hurley
Journal:  J Ment Health Adm       Date:  1994

Review 2.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

3.  Experiences with psychiatric referrals.

Authors:  S J Kiraly
Journal:  Can Fam Physician       Date:  1980-10       Impact factor: 3.275

4.  Who becomes chronic?

Authors:  J K Wing
Journal:  Psychiatr Q       Date:  1978

5.  The effects of culture-compatible intervention on the utilization of mental health services by minority clients.

Authors:  J H Flaskerud
Journal:  Community Ment Health J       Date:  1986

6.  Multidimensional study of the outcome of schizophrenic patients 1 year after clinic discharge. Predictors and influence of neuroleptic treatment.

Authors:  W Gaebel; A Pietzcker
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

7.  Community support services and functioning of the seriously mentally ill.

Authors:  F Baker; D Jodrey; J Intagliata; H Straus
Journal:  Community Ment Health J       Date:  1993-08

Review 8.  Pharmacologic features and effects of neuroleptics.

Authors:  M V Seeman
Journal:  Can Med Assoc J       Date:  1981-10-15       Impact factor: 8.262

9.  [Relevant predictors of the 5 year outcome of patients with schizophrenic or similar paranoid psychoses (author's transl)].

Authors:  H J Möller; K Werner-Eilert; M Wüschner-Stockheim; D von Zerssen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

10.  Plasma levels of fluphenazine and prolactin in psychiatric patients.

Authors:  T Kitamura; D A McGovern; N W Imlah; D Wiles; A A Schiff
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.